sabril 500 mg granulat til oral opløsning
orifarm a/s - vigabatrin - granulat til oral opløsning - 500 mg
vigabatrin "paranova" 500 mg granulat til oral opl?sning
paranova danmark a/s - vigabatrin - granulat til oral opløsning - 500 mg
xtandi
astellas pharma europe b.v. - enzalutamide - prostatiske neoplasmer - endokrine terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
depakine retard 500 mg depottabletter
2care4 aps - natriumvalproat, valproinsyre - depottabletter - 500 mg
fenemal "sad" 100 mg/ml injektionsvæske, opløsning
amgros i/s - phenobarbital - injektionsvæske, opløsning - 100 mg/ml
fenemal "sad" 10 mg/ml injektionsvæske, opløsning
amgros i/s - phenobarbital - injektionsvæske, opløsning - 10 mg/ml
orfiril 100 mg/ml injektionsvæske, opløsning
desitin arzneimittel gmbh - natriumvalproat - injektionsvæske, opløsning - 100 mg/ml
orfiril long 150 mg depotkapsler, hårde
desitin arzneimittel gmbh - natriumvalproat - depotkapsler, hårde - 150 mg
primidon "orifarm" 250 mg tabletter
orifarm generics a/s - primidonum - tabletter - 250 mg
primidon "orifarm" 50 mg tabletter
orifarm generics a/s - primidonum - tabletter - 50 mg